| Dr Molly Detgen Magnano, MD | |
|
2850 Telegraph Ave, 120, Berkeley, CA 94705-1192 | |
| (510) 204-8120 | |
| (510) 649-1238 |
| Full Name | Dr Molly Detgen Magnano |
|---|---|
| Gender | Female |
| Speciality | Rheumatology |
| Experience | 23 Years |
| Location | 2850 Telegraph Ave, Berkeley, California |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1992743579 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207RR0500X | Internal Medicine - Rheumatology | A80346 (California) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| California Pacific Medical Center- Van Ness Campus | San francisco, CA | Hospital |
| Alta Bates Summit Medical Center - Alta Bates Camp | Berkeley, CA | Hospital |
| California Pacific Medical Ctr-davies Campus Hosp | San francisco, CA | Hospital |
| Ucsf Medical Center | San francisco, CA | Hospital |
| Novato Community Hospital | Novato, CA | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Pacific Rheumatology Associates Medical Group | 0244312064 | 4 |
| Ucsf Medical Group Business Services | 3779497870 | 1064 |
| University Of California San Francisco | 4486567229 | 1298 |
News Archive
The U.S. Food and Drug Administration today approved Afrezza (insulin human) Inhalation Powder, a rapid-acting inhaled insulin to improve glycemic control in adults with diabetes mellitus. Afrezza is a rapid-acting inhaled insulin that is administered at the beginning of each meal, or within 20 minutes after starting a meal.
A new twins study from the Netherlands has found that genetic factors appear to be involved in the early initiation of alcohol use, while common environmental factors become involved once alcohol use has begun.
Olympus Medical is proud to announce their partnership with one of London's largest and busiest teaching hospitals King's College Hospital (KCH), with the aim of improving patient care, as well as overall efficiency.
Children who undergo simple emergency surgeries, such as hernia repairs or appendix removals, on weekends are more likely to suffer complications and even die than children getting the same kind of treatment during the week, according to results of a Johns Hopkins Children's Center study.
Seattle Genetics, Inc. today announced the initiation of a phase Ib clinical trial evaluating SGN-75 in combination with everolimus (Afinitor) for patients with advanced metastatic renal cell carcinoma (RCC).
› Verified 3 days ago
| Entity Name | Regents Of The University Of California |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1881763597 PECOS PAC ID: 4284547274 Enrollment ID: O20031106000389 |
News Archive
The U.S. Food and Drug Administration today approved Afrezza (insulin human) Inhalation Powder, a rapid-acting inhaled insulin to improve glycemic control in adults with diabetes mellitus. Afrezza is a rapid-acting inhaled insulin that is administered at the beginning of each meal, or within 20 minutes after starting a meal.
A new twins study from the Netherlands has found that genetic factors appear to be involved in the early initiation of alcohol use, while common environmental factors become involved once alcohol use has begun.
Olympus Medical is proud to announce their partnership with one of London's largest and busiest teaching hospitals King's College Hospital (KCH), with the aim of improving patient care, as well as overall efficiency.
Children who undergo simple emergency surgeries, such as hernia repairs or appendix removals, on weekends are more likely to suffer complications and even die than children getting the same kind of treatment during the week, according to results of a Johns Hopkins Children's Center study.
Seattle Genetics, Inc. today announced the initiation of a phase Ib clinical trial evaluating SGN-75 in combination with everolimus (Afinitor) for patients with advanced metastatic renal cell carcinoma (RCC).
› Verified 3 days ago
| Entity Name | University Of California San Francisco |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1861578973 PECOS PAC ID: 4486567229 Enrollment ID: O20031212000897 |
News Archive
The U.S. Food and Drug Administration today approved Afrezza (insulin human) Inhalation Powder, a rapid-acting inhaled insulin to improve glycemic control in adults with diabetes mellitus. Afrezza is a rapid-acting inhaled insulin that is administered at the beginning of each meal, or within 20 minutes after starting a meal.
A new twins study from the Netherlands has found that genetic factors appear to be involved in the early initiation of alcohol use, while common environmental factors become involved once alcohol use has begun.
Olympus Medical is proud to announce their partnership with one of London's largest and busiest teaching hospitals King's College Hospital (KCH), with the aim of improving patient care, as well as overall efficiency.
Children who undergo simple emergency surgeries, such as hernia repairs or appendix removals, on weekends are more likely to suffer complications and even die than children getting the same kind of treatment during the week, according to results of a Johns Hopkins Children's Center study.
Seattle Genetics, Inc. today announced the initiation of a phase Ib clinical trial evaluating SGN-75 in combination with everolimus (Afinitor) for patients with advanced metastatic renal cell carcinoma (RCC).
› Verified 3 days ago
| Entity Name | Ucsf Medical Group Business Services |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1477624104 PECOS PAC ID: 3779497870 Enrollment ID: O20040622001513 |
News Archive
The U.S. Food and Drug Administration today approved Afrezza (insulin human) Inhalation Powder, a rapid-acting inhaled insulin to improve glycemic control in adults with diabetes mellitus. Afrezza is a rapid-acting inhaled insulin that is administered at the beginning of each meal, or within 20 minutes after starting a meal.
A new twins study from the Netherlands has found that genetic factors appear to be involved in the early initiation of alcohol use, while common environmental factors become involved once alcohol use has begun.
Olympus Medical is proud to announce their partnership with one of London's largest and busiest teaching hospitals King's College Hospital (KCH), with the aim of improving patient care, as well as overall efficiency.
Children who undergo simple emergency surgeries, such as hernia repairs or appendix removals, on weekends are more likely to suffer complications and even die than children getting the same kind of treatment during the week, according to results of a Johns Hopkins Children's Center study.
Seattle Genetics, Inc. today announced the initiation of a phase Ib clinical trial evaluating SGN-75 in combination with everolimus (Afinitor) for patients with advanced metastatic renal cell carcinoma (RCC).
› Verified 3 days ago
| Entity Name | Pacific Rheumatology Associates Medical Group |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1770576431 PECOS PAC ID: 0244312064 Enrollment ID: O20080131000397 |
News Archive
The U.S. Food and Drug Administration today approved Afrezza (insulin human) Inhalation Powder, a rapid-acting inhaled insulin to improve glycemic control in adults with diabetes mellitus. Afrezza is a rapid-acting inhaled insulin that is administered at the beginning of each meal, or within 20 minutes after starting a meal.
A new twins study from the Netherlands has found that genetic factors appear to be involved in the early initiation of alcohol use, while common environmental factors become involved once alcohol use has begun.
Olympus Medical is proud to announce their partnership with one of London's largest and busiest teaching hospitals King's College Hospital (KCH), with the aim of improving patient care, as well as overall efficiency.
Children who undergo simple emergency surgeries, such as hernia repairs or appendix removals, on weekends are more likely to suffer complications and even die than children getting the same kind of treatment during the week, according to results of a Johns Hopkins Children's Center study.
Seattle Genetics, Inc. today announced the initiation of a phase Ib clinical trial evaluating SGN-75 in combination with everolimus (Afinitor) for patients with advanced metastatic renal cell carcinoma (RCC).
› Verified 3 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Molly Detgen Magnano, MD 2850 Telegraph Ave, 120, Berkeley, CA 94705-1192 Ph: (510) 204-8120 | Dr Molly Detgen Magnano, MD 2850 Telegraph Ave, 120, Berkeley, CA 94705-1192 Ph: (510) 204-8120 |
News Archive
The U.S. Food and Drug Administration today approved Afrezza (insulin human) Inhalation Powder, a rapid-acting inhaled insulin to improve glycemic control in adults with diabetes mellitus. Afrezza is a rapid-acting inhaled insulin that is administered at the beginning of each meal, or within 20 minutes after starting a meal.
A new twins study from the Netherlands has found that genetic factors appear to be involved in the early initiation of alcohol use, while common environmental factors become involved once alcohol use has begun.
Olympus Medical is proud to announce their partnership with one of London's largest and busiest teaching hospitals King's College Hospital (KCH), with the aim of improving patient care, as well as overall efficiency.
Children who undergo simple emergency surgeries, such as hernia repairs or appendix removals, on weekends are more likely to suffer complications and even die than children getting the same kind of treatment during the week, according to results of a Johns Hopkins Children's Center study.
Seattle Genetics, Inc. today announced the initiation of a phase Ib clinical trial evaluating SGN-75 in combination with everolimus (Afinitor) for patients with advanced metastatic renal cell carcinoma (RCC).
› Verified 3 days ago
Dr. Ellen C Morrissey, MD Rheumatology Medicare: Accepting Medicare Assignments Practice Location: 2905 Telegraph Ave, Berkeley, CA 94705 Phone: 510-841-0411 Fax: 510-845-5030 | |
Gerald L. Meyers, M.D. Rheumatology Medicare: Not Enrolled in Medicare Practice Location: 2450 Ashby Ave, Berkeley, CA 94705 Phone: 510-204-1894 Fax: 510-841-0435 | |
Dr. Josie A Tebben, MD Rheumatology Medicare: Medicare Enrolled Practice Location: 2905 Telegraph Ave, Berkeley, CA 94705 Phone: 510-841-0411 Fax: 510-845-5030 | |
Dr. David Harris Kadan, MD Rheumatology Medicare: Not Enrolled in Medicare Practice Location: U C Berkeley University Health, 2222 Bancroft Way, #4300, Berkeley, CA 94720 Phone: 510-642-2000 | |
Jenna T Dean, MD Rheumatology Medicare: Accepting Medicare Assignments Practice Location: 2540 Ashby Ave, Room 5505, Berkeley, CA 94705 Phone: 510-204-4444 Fax: 510-649-8287 | |
Kavita S Patankar, MD Rheumatology Medicare: Accepting Medicare Assignments Practice Location: 2450 Ashby Ave Rm 5505, Berkeley, CA 94705 Phone: 510-204-4444 Fax: 510-649-8287 | |
Dr. John Edward Swartzberg, MD Rheumatology Medicare: Not Enrolled in Medicare Practice Location: 570 University Hall, University Of California, Berkeley, Berkeley, CA 94720 Phone: 510-643-0499 |